Evidence-Based Deep Dive

NeuroLife, the market-facing brand of ActivateNeuro, Inc., has launched out of a strategic partnership between Battelle and The NeuroTech Institute to develop non-invasive neurotechnology for stroke and spinal cord injury rehabilitation.
The company’s core product is a wearable sleeve that reads elec

Nanoflex Robotics AG has secured €12.5 million in blended financing from the prestigious European Innovation Council Accelerator, consisting of a €2.5 million grant and a €10 million equity investment. The company was one of only 38 businesses selected across Europe from a pool of approximately 1,00

Hancock Prospecting has invested USD $50 million in Lumitron, with the option to increase its funding to USD $100 million this year. This capital injection is dedicated to the commercial scale-up of Lumitron’s HyperVIEW platform, an advanced medical imaging and radiotherapy technology originally dev

Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing.
The study, led by Dr. Andrew Morokoff at Royal Melbourne Hospital, evaluates the system during brain tumor resection surgery. Cipher uses a f

Pulsenmore Ltd. has announced a $7.5 million private placement with a single healthcare-focused institutional investor to support the next phase of its commercial growth.
The company plans to use the proceeds to expand its U.S. commercial footprint, increase market penetration, fund marketing and com

Kalogon has secured $5.75 million in new funding to accelerate global expansion of its smart seating technologies designed to reduce the health risks associated with prolonged sitting. The round was led by Enable Ventures, with participation from Florida Opportunity Fund, Castellan Group, and existi

Estonian medtech company Nanordica Medical has secured €1.6 million in funding to accelerate development of its nanotechnology-based wound care platform for chronic and infected wounds.
The round was led by 2C Ventures, with participation from Specialist VC, Superangel, Amalfi, the Health Founders sy

Onkos Surgical has received FDA 510(k) clearance to extend its NanoCept antibacterial technology to titanium implants within the ELEOS Limb Salvage System, broadening the use of its infection-resistant implant coating in complex orthopedic procedures.
The clearance represents the second 510(k) author

Australian medtech startup Oli has raised $6.5 million in Series A3 funding to accelerate development of its wearable technology designed to predict birth complications before they occur.
The round was backed by Scale Investors, Clare Ventures, and the University of Sydney, bringing Oli’s total priva